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time, results in the development of noncaseating granulo¬ mas. Previous studies demonstrated that this antigen-driven process involves the proliferation of CD4+ T lymphocytes. We hypothesize that disease results from changes in T helper 1 (Thl) (1) berylliumstimulated release ofIL-2 and IFN-7, but not IL-4; (2) high levels of IFN-7 (7 to 10 ng/mL) sustained to 168 h in cul¬ ture; (3) (Fig 1, left [A] ). Baseline bronchoscopy performed 3 months away from exposure on one subject showed fewer memory T cells, a normal CD4/CD8 ratio (2.41), and persistent activated T cells, compared with after isocyanate challenge (Fig 1, left [A] ).
Similar flow cytometry studies were performed on pe¬ ripheral blood mononuclear cells before and up to 48 h af¬ ter isocyanate challenge. Two of the isocyanate asthmatics showed an increase in total peripheral lymphocytes, total T cells, and T cells expressing HLA-DR+ and IL-2R+ after challenge (Fig 1, right [B] ). These patients also showed a shift in their CD4+ cells from a "naive" immunophenotype (CD45+ RA+RO") to a memoryphenotype (CD45+ RA"RO+) in their peripheral blood and BAL (Fig 1, left [A] 
